A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke

NCT05515393 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

420

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Ischemic Stroke

Interventions

DRUG: XY03-EA
DRUG: XY03-EA Placebo

Sponsor

Shijiazhuang Yiling Pharmaceutical Co. Ltd

Collaborators

[object Object]